Medical/Pharmaceuticals
SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study
Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer Large-scale, multicentric real-world study aims to enro...
2021-12-02 02:30
2887
When and How to Screen for Colorectal Cancer? New NCCN Patient Guideline Explains Latest Timing and Approaches
PLYMOUTH MEETING, Pa., Dec. 1, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®) today announced the publication of new NCCN Guidelines for Patients®: Colorectal Cancer Screening. Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer inthe United States, with...
2021-12-01 21:37
2994
VIRALEZE™ antiviral nasal spray registered in Vietnam with launch to follow this week
MELBOURNE, Australia, Dec. 1, 2021 /PRNewswire/ -- Australian biotech company
Starpharma
2021-12-01 16:40
3152
Dawn Health set out to revolutionize digitalization of the global life science industry with new investment round
COPENHAGEN, Denmark, Dec. 1, 2021 /PRNewswire/ -- Dawn Health, a global leader in digital health, has received aUSD 25 million investment from a consortium of highly experienced investors. The consortium counts Chr. Augustinus Fabrikker, Vaekstfonden - The Danish Growth Fund, and Lars Marcher. Th...
2021-12-01 16:35
2098
World Federation of Neurology Impresses Importance of Brain Health Through Global Public Initiative
LONDON, Dec. 1, 2021 /PRNewswire/ -- The World Federation of Neurology (WFN) is leading the charge on advocating for brain health awareness, through the launch of its Brain Health Initiative (BHI), a program created to reduce the immense global burden of brain diseases and disorders. Neurological...
2021-12-01 16:22
2534
Harrison.ai raises AUD$129 million and partners with Sonic Healthcare to develop pathology AI, accelerating its mission to expand capacity of global healthcare
$129 million funding raised from global venture firms and strategic investors including Horizons Ventures, I-MED Radiology and Sonic Healthcare in one of Australia's largest Series B funding rounds ever New pathology Joint Venture combines Harrison.ai's expertise in clinical artificial intelligen...
2021-12-01 13:01
2824
GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan
TOKYO and SINGAPORE, Dec. 1, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture,Japan, today announces a strategic agreement for joint research a...
2021-12-01 12:03
6580
Sai Life Sciences' pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan
HYDERABAD, India, Dec. 1, 2021 /PRNewswire/ -- Sai Life Sciences, a leading
global Contract Research, Development & Manufacturing Organization
2021-12-01 09:00
4387
Lynk Pharmaceuticals Announced First Patient Dosed in Phase II Clinical Study of LNK01001
HANGZHOU, China, Dec. 1, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced the company has dosed the first patient with LNK01001 in its Phase II clinical trial in subjects with rheumatoid arthri...
2021-12-01 08:00
4832
Everest Medicines and Providence Therapeutics Jointly Announce Vaccine Development Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant
SHANGHAI and CALGARY, Canada, Dec. 1, 2021 /PRNewswire/ -- Everest Medicines and Providence Therapeutics ("Providence") jointly announced today that the companies have started working on a new version of COVID-19 vaccine specifically targeting the new Omicron variant. Scientists from the two com...
2021-12-01 08:00
3960
Innovent Biologics and Ascentage Pharma Announce the China NMPA Approval for China's First Third-Generation BCR-ABL Inhibitor Olverembatinib for the Treatment of Chronic Myeloid Leukemia
SUZHOU, China, SAN FRANCISCO and ROCKVILLE, Md., Dec. 1, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and...
2021-12-01 08:00
4489
EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants
PROVIDENCE, R.I., Dec. 1, 2021 /PRNewswire/ -- Today EpiVax, Inc. ("EpiVax") confirmed that the company'sEPV-CoV-19 vaccine epitopes are 98.2% conserved in the new Omicron SARS-CoV-2 variant. EpiVax and EpiVax Therapeutics, Inc. ("EVT") are also affirming commitment to move the novel T cell epito...
2021-12-01 05:22
2912
Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using Insilico's Proprietary End-to-end Artificial Intelligence Platform
NEW YORK and HONG KONG, Dec. 1, 2021 /PRNewswire/ -- Insilico Medicine, an
end-to-end artificial intelligence (AI)-driven drug discovery company,today
announced that the first healthy volunteer has been dosed in a first-in-human
microdose trial of ISM001-055.
2021-12-01 05:00
4682
RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results
RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against Omicron Acting independently of spike protein mutation, opaganib and RHB-107's unique host-targeted mechanisms of action hold potential versus Omicron and other variants -- Phase 2/3 study s...
2021-11-30 22:30
5232
New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care
As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US centralized laboratory where itsCELLSEARCH® technology can enumerateCirculating Multiple Myeloma Cells (CMMCs) f...
2021-11-30 22:18
3593
NeoLight Acquires Occular Screening Leader Phoenix Technology Group, Strengthening the Company's Newborn Care Global Strategy
SCOTTSDALE, Ariz., Nov. 30, 2021 /PRNewswire/ -- NeoLight LLC (NeoLight), an ASU spinout and anArizona based newborn medical device company, today announced it has acquired Phoenix Technology Group LLC (PTG), a leading provider of advanced ophthalmic imaging devices, including a telemedicine plat...
2021-11-30 21:00
2184
Jemincare Announces the Exclusive License of the Kras Inhibitor to HUYABIO
SHANGHAI, Nov. 30, 2021 /PRNewswire/ -- Jemincare, a leading pharmaceutical company fromChina, announced today its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., had licensed exclusive worldwide ex-China rights to the Kras inhibitor, JMKX1899, to HUYABIO Internation...
2021-11-30 20:42
4730
George Clinical Applauded by Frost & Sullivan for Improving Clinical Trial Efficiency and Patient-centricity through Impactful, Strategic Partnerships
Innovation through impactful, strategic partnerships improves efficiency and delivers scientific leadership and patient-centricity in clinical trials execution. SANTA CLARA, Calif., Nov. 30, 2021 /PRNewswire/ -- Based on its recent analysis of theAsia-Pacific clinical contract research organizat...
2021-11-30 20:33
2368
Treadwell Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of TTK inhibitor, CFI-402257
NEW YORK and HONG KONG, Nov. 30, 2021 /PRNewswire/ -- Treadwell Therapeutics, a clinical stage biotechnology company developing novel therapeutics for highly aggressive cancers, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) applic...
2021-11-30 20:00
4755
Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant
SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay is capable of detecting the Omicron's unique pattern of mutations. The well-established PCR-based test recogni...
2021-11-30 19:25
3500
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 292 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 281 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 279 media titles]
2026-10-15 12:59
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21Most Read
Amap and Sands China mark the delivery of the first Tutu robots, with expected indoor navigation and 3D resort previews
2026-10-10 16:43
15237
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
2026-10-13 10:00
12340
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
12237